B. Metzler Seel. Sohn & Co. Ag Incyte Corp Transaction History
B. Metzler Seel. Sohn & Co. Ag
- $10 Billion
- Q3 2024
A detailed history of B. Metzler Seel. Sohn & Co. Ag transactions in Incyte Corp stock. As of the latest transaction made, B. Metzler Seel. Sohn & Co. Ag holds 4,421 shares of INCY stock, worth $327,861. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,421
Previous 4,421
-0.0%
Holding current value
$327,861
Previous $268,000
8.96%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding INCY
# of Institutions
657Shares Held
186MCall Options Held
714KPut Options Held
557K-
Baker Bros. Advisors LP New York, NY30.7MShares$2.28 Billion21.76% of portfolio
-
Black Rock Inc. New York, NY21.4MShares$1.58 Billion0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA20.4MShares$1.51 Billion0.02% of portfolio
-
Dodge & Cox San Francisco, CA15.3MShares$1.13 Billion0.61% of portfolio
-
State Street Corp Boston, MA10.6MShares$782 Million0.03% of portfolio
About INCYTE CORP
- Ticker INCY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 222,431,008
- Market Cap $16.5B
- Description
- Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...